InvestorsHub Logo
Followers 56
Posts 14300
Boards Moderated 0
Alias Born 01/19/2009

Re: NewMoney post# 139431

Tuesday, 05/22/2018 2:02:01 PM

Tuesday, May 22, 2018 2:02:01 PM

Post# of 146291
And Theracour-Diwan hasn't licensed rights for VZV to NNVC-Diwan.

According to the new 10-Q, this now won't happen until sometime after a new CEO is hired:

"The Company has declared its intent to license VZV (shingles) and the remaining human herpesviruses from TheraCour, and has conducted a valuation for the shingles and PHN indications recently. The Company intends to complete the negotiations after the appointment of a new Chief Executive Officer."

p.8 https://www.sec.gov/Archives/edgar/data/1379006/000114420418030083/tv492966_10q.htm


Ergo, it won't happen.

A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News